Hidden culprit: Human metapneumovirus identified in severe adult pneumonia case

The FDA approved sofpironium topical gel 12.45% (Sofdra) for primary axillary hyperhidrosis, according to a statement from Botanix Pharmaceuticals. The approval stipulates use in adults

Unlike a behavioral intervention, nasal sprays were effective in reducing days of illness among high-risk groups vulnerable to respiratory infections, a large randomized controlled trial

A Change.org petition calling for an end to maintenance of certification (MOC) requirements, administered by the American Board of Internal Medicine (ABIM), has reached 10,500